Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Molecular Alterations in Adult Histiocytic Neoplasms

Gaurav Goyal, MBBS, Jithma P. Abeykoon, MD, Nora N Bennani, MD, Minetta C Liu, MD, Mithun Vinod Shah, MD PhD, Ronald S. Go, MD

Blood (2019) 134 (Supplement_1): 2975.

https://doi.org/10.1182/blood-2019-122286

Published: 2019

Journal Articles

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

Filip Janku, MD PhD, Harsh Patel, BS, Vaijayanthi Kandadai Raghavan, Aaron Goodman, Tamara G. Barnes, Razelle Kurzrock, MD

Blood (2019) 134 (Supplement_1): 2319.

https://doi.org/10.1182/blood-2019-126342

Published: 2019

Journal Articles

S100B Is a Useful Marker for the Diagnosis of Haemophagocytic Lymphohistiocytosis

Rosemarie Tremblay-Lemay, MD MSc, FRCPC, Lourdes Calvente, MD, Monali Gupta, MD, Anne Tierens, MD PhD, David Barth, MD, John Kuruvilla, MD, Jan M.A. Delabie, MD PhD

Blood (2018) 132 (Supplement 1): 3711.

https://doi.org/10.1182/blood-2018-99-116783

Published: 2018

Journal Articles

Clonal T-Large Granular Lymphocyte Proliferations in Childhood: Friend or Foe?

Sureyya Savasan, MD, Batool Al-Qanber, MD, Steven Buck, MS, Erin Wakeling, PhD, Manisha Gadgeel, MBBS, MS

Blood (2018) 132 (Supplement 1): 3719.

https://doi.org/10.1182/blood-2018-99-119124

Published: 2018

Journal Articles

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Gaurav Goyal, MBBS, Robert Vassallo, MD, Karen L Rech, MD, Jay H Ryu, MD, Caroline J Davidge-Pitts, MBBCh, W Oliver Tobin, MBBCh, PhD, Matthew J Koster, MD, Nabila Nora Bennani, MD, Mithun Vinod Shah, MD PhD, Minetta C Liu, MD, Ronald S. Go, MD

Blood (2018) 132 (Supplement 1): 1112.

https://doi.org/10.1182/blood-2018-99-113196

Published: 2018

Journal Articles

Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Sporadic and Familial Histiocytic Neoplasms

Benjamin H Durham, MD BS, Estibaliz Lopez-Rodrigo, MD, David H Abramson, MD, Jennifer Picarsic, MD, Alessandro Pastore, Diana Mandelker, MD PhD, Michael Francis Walsh, MD, Maria E Arcila, MD, Marc Ladanyi, MD, David Solit, MD, Michael F. Berger, PhD, David M. Hyman, MD, Michelle Ki, BSc, Ira Dunkel, MD, Frederic Geissmann, MD PhD, Eli L Diamond, MD, Omar I Abdel-Wahab, MD

Blood (2018) 132 (Supplement 1): 49.

https://doi.org/10.1182/blood-2018-99-114248

Published: 2018

Journal Articles

Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

Chiara Cantò, Hematologist in training, MD, Elena Ranucci, Pharmacist, Stefano Pulini, MD, Fiorenzo Santoleri, Pharmacist, Anna Maria Morelli, MD, Francesca Fioritoni, MD, Simona Falorio, MD, Lorenza Torti, PhD MD, Antonio Spadano, MD, Marianna D'Aloisio, MD, Mauro Di Ianni, MD PhD, Stella Santarone, MD, Paolo Di Bartolomeo, MD

Blood (2018) 132 (Supplement 1): 5653.

https://doi.org/10.1182/blood-2018-99-112595

Published: 2018

Journal Articles

Acquired Hematologic Disorders of Ras-MAPK Activation

Carl E. Allen, MD PhD

Blood (2018) 132 (Supplement 1): SCI-42.

https://doi.org/10.1182/blood-2018-99-109380

Published: 2018

Journal Articles

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Oussama Abla, Eric Jacobsen, Jennifer Picarsic, Zdenka Krenova, Ronald Jaffe, Jean-Francois Emile, Benjamin H. Durham, Jorge Braier, Frédéric Charlotte, Jean Donadieu, Fleur Cohen-Aubart, Carlos Rodriguez-Galindo, Carl Allen, James A. Whitlock, Sheila Weitzman, Kenneth L. McClain, Julien Haroche, Eli L. Diamond

Blood (2018) 131 (26): 2877–2890.

https://doi.org/10.1182/blood-2018-03-839753

Published: 2018

Journal Articles

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Gaurav Goyal, MBBS, Aishwarya Ravindran, MBBS, Mrinal M. Patnaik, MDMBBS, Grzegorz S Nowakowski, MD, Gita Thanarajasingam, MD, Thomas M Habermann, MD, Taimur Sher, MD, Karen L Rech, MD, David J Inwards, MD, Patrick B Johnston, MD PhD, Robert Vassallo, MD, Sameer A. Parikh, MD, Ronald S. Go, MD

Blood (2017) 130 (Supplement 1): 3573.

https://doi.org/10.1182/blood.V130.Suppl_1.3573.3573

Published: 2017

Journal Articles

Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders

Eli L Diamond, MD, Benjamin H Durham, MD BS, Ahmet Dogan, MD PhD, David M. Hyman, MD, Raajit K. Rampal, MD PhD, Gary Ulaner, MD, Lynn Brody, MD, Omar Abdel-Wahab, MD

Blood (2017) 130 (Supplement 1): 257.

https://doi.org/10.1182/blood.V130.Suppl_1.257.257

Published: 2017

Journal Articles

Real-Time Genomic Profiling Identifies Novel Mutations and Improved Therapy for Histiocytoses

Lynn Lee, MD, Anjelika Gasilina, Jayeeta Roychoudhury, PhD, Jason Clark, Francis X McCormack, MD, Joseph Gerald Pressey, MD, Robert B. Lorsbach, MD PhD, Siraj M Ali, MD PhD, Mark Bailey, MSc, Philip Stevens, PhD, Jeffrey S Ross, MD, Vincent A. Miller, MD, Nicolas Nassar, PhD, Ashish R Kumar, MBBS, PhD

Blood (2016) 128 (22): 2723.

https://doi.org/10.1182/blood.V128.22.2723.2723

Published: 2016

Journal Articles

Efficacy and Toxicity Profile of Clofarabine in Patients with Recurrent/Refractory Langerhans Cell Histiocytosis and Other Histiocytic Disorders

Olive S. Eckstein, MD, Racheal Bingham, CPNP, Erin Christine Peckham, PhD MPH, Austin Brown, MPH, PhD, Carl E. Allen, MD PhD, Kenneth L. McClain, MD PhD

Blood (2016) 128 (22): 1329.

https://doi.org/10.1182/blood.V128.22.1329.1329

Published: 2016

Journal Articles

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Blood (2016) 127 (22): 2672–2681.

https://doi.org/10.1182/blood-2016-01-690636

Published: 2016

Includes: Supplemental data

Journal Articles

Evaluation of Clinicopathologic Characteristics and the BRAF V600E Mutation in Erdheim-Chester Disease Among Chinese Adults

Xin-xin Cao, MD, Jian Sun, MD, Jian Li, MD, Ding-rong Zhong, MD, Na Niu, Bachelor, Ming-hui Duan, MD, Zhi-yong Liang, MD, Dao-bin Zhou, MD

Blood (2015) 126 (23): 3870.

https://doi.org/10.1182/blood.V126.23.3870.3870

Published: 2015

Journal Articles

Mutually Exclusive Recurrent Somatic Mutations in MAP2K1 and BRAF Support a Central Role for ERK Activation in LCH Pathogenesis

Rikhia Chakraborty, PhD

Blood (2014) 124 (21): 5587.

https://doi.org/10.1182/blood.V124.21.5587.5587

Published: 2014

Journal Articles

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Blood (2014) 124 (19): 3007–3015.

https://doi.org/10.1182/blood-2014-05-577825

Published: 2014

Includes: Supplemental data

Journal Articles

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Richard McMasters, MD, Brian K. Turpin, DO, Michael J. Absalon, MD, PhD, Christine L. Phillips, MD, Karen Burns, MD, Christopher E. Dandoy, MD, Nihal Bakeer, MBBS, Jun Mo, MD, John Perentesis, MD, Maureen M. O'Brien, MD

Blood (2013) 122 (21): 4940.

https://doi.org/10.1182/blood.V122.21.4940.4940

Published: 2013

Journal Articles

Increased risk of CVD after VT is determined by common etiologic factors

Rachel E. J. Roach, Willem M. Lijfering, Linda E. Flinterman, Frits R. Rosendaal, Suzanne C. Cannegieter

Blood (2013) 121 (24): 4948–4954.

https://doi.org/10.1182/blood-2013-01-479238

Published: 2013

Includes: Supplemental data

Journal Articles

The Risk of Venous Thrombosis in Different Immigrant Groups in the Netherlands

Suely M Rezende, Willem M. Lijfering, PhD, Frits R. Rosendaal, Suzanne C. Cannegieter, MD, PhD

Blood (2012) 120 (21): 3393.

https://doi.org/10.1182/blood.V120.21.3393.3393

Published: 2012

NARROW

Molecular Alterations in Adult Histiocytic Neoplasms

MEK Inhibition with Trametinib in Patients with Non-Langerhans Cell Histiocytosis

S100B Is a Useful Marker for the Diagnosis of Haemophagocytic Lymphohistiocytosis

Clonal T-Large Granular Lymphocyte Proliferations in Childhood: Friend or Foe?

Tumor Mutational Burden and Other Immunotherapy Markers in Histiocytic Neoplasms Using Next Generation Sequencing

Activating Mutations in CSF1R and Additional Receptor Tyrosine Kinases in Sporadic and Familial Histiocytic Neoplasms

Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: A Single-Center Real Life Experience

Acquired Hematologic Disorders of Ras-MAPK Activation

Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease

Clinical Features and Treatment Approaches in Patients with Rosai-Dorfman Disease: The Mayo Clinic Experience

Phase 2 Trial of Single-Agent Cobimetinib for Adults with BRAF V600-Mutant and Wild-Type Histiocytic Disorders

Real-Time Genomic Profiling Identifies Novel Mutations and Improved Therapy for Histiocytoses

Efficacy and Toxicity Profile of Clofarabine in Patients with Recurrent/Refractory Langerhans Cell Histiocytosis and Other Histiocytic Disorders

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

Evaluation of Clinicopathologic Characteristics and the BRAF V600E Mutation in Erdheim-Chester Disease Among Chinese Adults

Mutually Exclusive Recurrent Somatic Mutations in MAP2K1 and BRAF Support a Central Role for ERK Activation in LCH Pathogenesis

Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis

Genomic Characterization Of Histiocytic Lesions Following Pediatric T-Cell Acute Lymphoblastic Leukemia

Increased risk of CVD after VT is determined by common etiologic factors

The Risk of Venous Thrombosis in Different Immigrant Groups in the Netherlands

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only